These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 33450841)
1. Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL. Schilcher I; Stadler JT; Lechleitner M; Hrzenjak A; Berghold A; Pregartner G; Lhomme M; Holzer M; Korbelius M; Reichmann F; Springer A; Wadsack C; Madl T; Kratky D; Kontush A; Marsche G; Frank S Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450841 [TBL] [Abstract][Full Text] [Related]
2. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo. Gugliucci A Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342 [TBL] [Abstract][Full Text] [Related]
3. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins. Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725 [TBL] [Abstract][Full Text] [Related]
4. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation. Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818 [TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase enzyme activity and oxidative stress in obese subjects. Aslan M; Horoz M; Sabuncu T; Celik H; Selek S Pol Arch Med Wewn; 2011 Jun; 121(6):181-6. PubMed ID: 21694681 [TBL] [Abstract][Full Text] [Related]
6. Associations between Endothelial Lipase, High-Density Lipoprotein, and Endothelial Function Differ in Healthy Volunteers and Metabolic Syndrome Patients. Klobučar I; Stadler JT; Klobučar L; Lechleitner M; Trbušić M; Pregartner G; Berghold A; Habisch H; Madl T; Marsche G; Frank S; Degoricija V Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768410 [TBL] [Abstract][Full Text] [Related]
7. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population. Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660 [TBL] [Abstract][Full Text] [Related]
8. Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study. Sutherland WH; de Jong SA; Walker RJ Nephrol Dial Transplant; 2004 Jan; 19(1):75-82. PubMed ID: 14671042 [TBL] [Abstract][Full Text] [Related]
9. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity. Sorenson RC; Bisgaier CL; Aviram M; Hsu C; Billecke S; La Du BN Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2214-25. PubMed ID: 10479665 [TBL] [Abstract][Full Text] [Related]
10. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. Gaidukov L; Tawfik DS Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586 [TBL] [Abstract][Full Text] [Related]
11. VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies. Rosenblat M; Ward S; Volkova N; Hayek T; Aviram M Biofactors; 2012; 38(4):292-9. PubMed ID: 22674772 [TBL] [Abstract][Full Text] [Related]
12. Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma. Kunes JP; Cordero-Koning KS; Lee LH; Lynch SM Nutr Res; 2009 Feb; 29(2):114-22. PubMed ID: 19285602 [TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. Rosenblat M; Karry R; Aviram M Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851 [TBL] [Abstract][Full Text] [Related]
14. Evidence for the presence of active paraoxonase 1 in small-dense low-density lipoprotein. Gugliucci A; Caccavello R; Kotani K; Kimura S Redox Rep; 2014 Jul; 19(4):154-60. PubMed ID: 24524596 [TBL] [Abstract][Full Text] [Related]
15. Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction. Gu X; Huang Y; Levison BS; Gerstenecker G; DiDonato AJ; Hazen LB; Lee J; Gogonea V; DiDonato JA; Hazen SL J Biol Chem; 2016 Jan; 291(4):1890-1904. PubMed ID: 26567339 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis. Olama SM; Elarman MM Rheumatol Int; 2013 Jun; 33(6):1487-94. PubMed ID: 23239038 [TBL] [Abstract][Full Text] [Related]
17. Effects of anaerobic training on paraoxonase-1 enzyme (PON1) activities of high density lipoprotein subgroups and its relationship with PON1-Q192R phenotype. Turgay F; Şişman AR; Aksu AÇ J Atheroscler Thromb; 2015; 22(3):313-26. PubMed ID: 25735253 [TBL] [Abstract][Full Text] [Related]